Diagnostic Value of Transvaginal Contrast-enhanced Ultrasound in Small Adnexal Masses

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-11001307

Enrollment

Unknown

Registered

2011-04-12

Start date

2009-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small adnexal masses (=<4cm)

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Series of patients with adnexal masses (=<4cm) confirmed in abdominal or transvaginal conventional ultrasound examination

Exclusion criteria

Exclusion criteria: 1. Patients with ovarian masses of 1-2cm, clear boundary, no echo and considered as follicular by abdominal or transvaginal ultrasound examination; 2. Patients with renal serious insufficiency; 3. Allergic to Sulphur Hexafluoride or composition of SonoVue, and deficiency in catalase; 4. Patients with right to left shunt heart diseases, severe pulmonary hypertension, uncontrolled hypertension; 5. Adult respiratory distress syndrome; 6. Pregnant and lactating women; 7. Aged below 18.

Design outcomes

Primary

Measure	Time frame
perfusion patterns of contrast-enhanced ultrasound;	—

Contacts

Public ContactHong XIANG

xianghong65@126.com+86 991 4363786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026